Comprehensive Breast Program Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Breast-Female Clinical Trials
18F-Fluoride PET/CT Versus 99mTc-MDP Scanning for Detecting Bone Metastases: A Randomized, Multi-Center Trial to Compare Two Bone Imaging Techniques
Breast-Female
W0847
Seltzer
A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
Breast-Female
NCIC-MA.32
Chamberlin
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
Breast-Female
S1007
Chamberlin
A Prospective Study of Partial Breast Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors
Breast-Female
D0929
Barth
A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Breast-Female
E2108
Schwartz
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence
Breast-Female
F11040
Schwartz
A Study to Evaluate the use of Supine MRI Images in Breast Conserving Surgery
Breast-Female
D0928
Barth
Alternative Breast Cancer Imaging Modalities: Correlation with Local Tissue Property Measurements and Histopathological Indices in Benign and Malignant Lesions
Breast-Female
D0404
Barth
An Open-Label Study of AMG 386 in Combination with Either Paclitaxel and Trastuzumab or Capecitabine and Lapatinib in Subjects with HER2-Positive Locally Recurrent or Metastatic Breast Cancer
Breast-Female
F0915
Kaufman
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Breast-Female
D0946
Bakitas
Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging (DOSI)
Breast-Female
ACRIN6691
Paulsen
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
Breast-Female
D0605
Kaufman
NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
Breast-Female
D1025
Kaufman
PBX1 Expression and Endocrine Resistance in Subjects with Breast Cancer
Breast-Female
D1058
Schwartz
Participation Restrictions in Young-Middle Adult Rural Breast Cancer Survivors
Breast-Female
D1032
Hegel
Phase II Placebo-Controlled Trial of Lisinopril and Coreg CR® to Reduce Cardiotoxicity in Patients with Breast Cancer Receiving (Neo)Adjuvant Chemotherapy with Trastuzumab (Herceptin®)
Breast-Female
SCUSF0806
Schwartz
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose- Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
Breast-Female
C40603
Chamberlin
Breast-Male Clinical Trials
A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Breast-Male
E2108
Schwartz
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Breast-Male
D0946
Bakitas
